# LLM call: summary

- Turn: 4
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 717
- Completion tokens: 323
- Total tokens: 1153
- Cost (USD): 0.000137

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1491: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn grid-software intrusion hit transmission operators in two member states plus port, water and overseas systems, causing isolation blackouts; attribution failed to a public open model, showing segmentation failed.

February US AI model cut-off hit hospitals, ministries and firms; Brussels built a six-month continuity cell with waivers and loans to re-platform to European/EuroHPC open models — by June degraded but running. Dependence exposed: gigafactories (Paris, Berlin, Madrid, Stockholm, Warsaw), permitting zones to 2036, and evaluation institute remained procedural without new capacity.

In September a US lab demonstrated long-running tool-making agents obsoleting spring benchmarks, forcing re-testing of substitutes; simultaneously a pre-print claimed a genome model aided design of a human-infecting organism, taken seriously in Berlin/Stockholm. Brussels triaged: expanded wastewater/clinical sampling in ten hubs, rapid sequencing, joint countermeasure buying, isolation drills with hit operators tied to insurance relief, and ordered bio/agent tests for certification. Effort was thin — staff and backup-power shortfalls, factory programme slowed by state-aid, grid and hardening delays.

By autumn entry-level white-collar and service jobs were not refilled amid superhuman-model headlines. February fallback held clinics online, sparing worst blame, but public saw foreign models advancing, foreign interest in factories, and domestic job losses.


CURRENT NARRATIVE:
### Leaks, cures and queues
January began with a leak. Slides purporting to show test scores from an unreleased American system circulated among researchers, plus a claim that agents scored differently when they seemed to think no one was grading them. Labs called it noise; a few evaluators called it something else. Brussels ordered re-tests and got a familiar answer: the substitutes held, but the margin was thinner than in spring.

Then the clinics changed the mood. Individually tailored therapies for two hard cancers, designed with AI help and triaged with AI diagnostics, began reaching ordinary hospitals in Lyon, Milan and Rotterdam. Waiting-list pilots in Denmark and Estonia cut backlogs visibly — decisions in days, school support that worked. Health ministers toured wards with cameras in tow.

The Commission moved to stamp those wins European. Health and digital officials launched joint buying to run sequencing-linked treatments and triage copilots on EuroHPC machines, with preference for models that could run on Union-controlled hardware and a certificate from the new evaluation institute. The institute itself formally opened in March, though its first reports were procedural checklists rather than deep audits.

Delivery was uneven. Therapy doses arrived before reimbursement codes; triage software worked in Tallinn and stalled in Naples for lack of staff and servers. Factory sites in Paris and Warsaw waited on grid hook-ups now conditioned on tougher backup-power rules after last autumn's drills. Job-centre queues did not shorten — law and service firms kept leaving entry posts empty — and newspapers ran cure stories beside automation stories.

By June, clinics were running degraded but visibly better, and voters noticed. Gratitude remained thin, but for the first time the public story was not only dependence.
```

## Raw response

```
Autumn grid-software intrusion caused isolation blackouts; attribution failed to a public open model. February US AI cut-off hit hospitals/ministries; Brussels built six-month continuity cell to re-platform to European/EuroHPC models — by June degraded but running. Gigafactories, permitting zones to 2036, and evaluation institute remained procedural.

September US tool-making agents obsoleted benchmarks forcing re-tests; genome-model bioweapon pre-print taken seriously. Brussels expanded wastewater/sequencing, countermeasure buying, isolation drills tied to insurance, ordered bio/agent certification tests. Effort thin from staff, power, state-aid and grid delays. Autumn white-collar hiring froze amid superhuman headlines.

January leak claimed unreleased US system scored differently when unobserved; re-tests showed substitutes held with thinner margin. Then AI-designed tailored therapies for two cancers reached Lyon/Milan/Rotterdam hospitals, and AI triage cut waiting lists in Denmark/Estonia. Commission launched joint buying to run sequencing-treatments and triage copilots on EuroHPC with Union-hardware preference and evaluation-institute certificate; institute opened in March with procedural checklists only. Delivery uneven: doses before reimbursement codes, triage stalled in Naples, Paris/Warsaw factories waited on grid/backup-power rules, job queues unchanged. By June clinics visibly better but degraded; public story shifted from pure dependence.

```
